New bone density treatment is a tried-and-true heart medication. The cost, efficacy and ease of administering nitroglycerin could mean a game-changer for treating thinning bones.
出版信息
Duke Med Health News. 2011 May;17(5):1-2.
PMID:21766529
Abstract
摘要
相似文献
1
2
[Men also need bone protection].
MMW Fortschr Med. 2006 Nov 16;148(46):48-9.
3
[New bone density conservation agents for osteoporosis under research and development: ED-71].[正在研发的用于骨质疏松症的新型骨密度保护剂：依替膦酸二钠（ED-71）]
Nihon Rinsho. 2007 Nov 28;65 Suppl 9:454-8.
4
[New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].[正在研发的用于骨质疏松症的新型骨密度保护剂：雷奈酸锶]
Nihon Rinsho. 2007 Nov 28;65 Suppl 9:447-53.
5
Lasofoxifene: new drug. Osteoporosis: no better than raloxifene.拉索昔芬：新药。骨质疏松症：效果不比雷洛昔芬好。
Prescrire Int. 2009 Dec;18(104):247.
6
Corticosteroids: no drug prevention of fractures needed.皮质类固醇：无需药物预防骨折。
Prescrire Int. 2009 Aug;18(102):175.
7
Is nitroglycerin a novel and inexpensive treatment for osteoporosis?硝酸甘油是一种治疗骨质疏松症的新颖且廉价的疗法吗？
JAMA. 2011 Feb 23;305(8):826-7. doi: 10.1001/jama.2011.191.
8
[Treatment of osteoporosis with parathyroid hormone].甲状旁腺激素治疗骨质疏松症
Tidsskr Nor Laegeforen. 2008 Jan 3;128(1):39-41.
9
Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis.中间型地中海贫血所致骨质疏松患者，尽管唑来膦酸使骨矿物质密度有所改善，但促红细胞生成活性仍持续增加。
Acta Haematol. 2008;119(1):40-4. doi: 10.1159/000114869. Epub 2008 Feb 5.
10
[Anabolic treatment for osteoporosis: PTH treatment].骨质疏松症的合成代谢治疗：甲状旁腺激素治疗
Clin Calcium. 2006 Sep;16(9):1480-85.
Zotero 插件